Larry L.  Wood net worth and biography

Larry Wood Biography and Net Worth

Larry L. Wood has been corporate vice president, Transcatheter Aortic Valve Replacement, since 2007, and has been responsible for key company R&D, operations, marketing, commercial, clinical and regulatory initiatives in transcatheter valve replacement around the globe since the program was a development project. Under his leadership, the Edwards SAPIEN heart valve has won numerous awards, including the Prix Galien “Best Medical Technology Product” award and was named Popular Science’s “Best of What’s New” Grand Award winner in the Health category. Wood has more than 25 years of experience in the medical device industry at both Edwards and Baxter International, and is a frequently invited faculty member at key interventional cardiology and cardiothoracic surgery scientific congresses. Wood previously held key positions in manufacturing management, regulatory affairs, and strategic and clinical marketing, primarily in the company’s leading surgical heart valve franchise. Wood received his master’s degree in business administration from Pepperdine University.

What is Larry L. Wood's net worth?

The estimated net worth of Larry L. Wood is at least $18.71 million as of December 13th, 2023. Mr. Wood owns 213,794 shares of Edwards Lifesciences stock worth more than $18,711,251 as of April 23rd. This net worth estimate does not reflect any other assets that Mr. Wood may own. Additionally, Mr. Wood receives an annual salary of $1,490,000.00 as VP at Edwards Lifesciences. Learn More about Larry L. Wood's net worth.

How old is Larry L. Wood?

Mr. Wood is currently 58 years old. There are 6 older executives and no younger executives at Edwards Lifesciences. The oldest executive at Edwards Lifesciences is Mr. Arnold A. Pinkston, Corporate VP & General Counsel, who is 65 years old. Learn More on Larry L. Wood's age.

What is Larry L. Wood's salary?

As the VP of Edwards Lifesciences Co., Mr. Wood earns $1,490,000.00 per year. The highest earning executive at Edwards Lifesciences is Mr. Bernard J. Zovighian, CEO & Director, who commands a salary of $2,270,000.00 per year. Learn More on Larry L. Wood's salary.

How do I contact Larry L. Wood?

The corporate mailing address for Mr. Wood and other Edwards Lifesciences executives is ONE EDWARDS WAY, IRVINE CA, 92614. Edwards Lifesciences can also be reached via phone at (949) 250-2500 and via email at [email protected]. Learn More on Larry L. Wood's contact information.

Has Larry L. Wood been buying or selling shares of Edwards Lifesciences?

Larry L. Wood has not been actively trading shares of Edwards Lifesciences during the last ninety days. Most recently, Larry L. Wood sold 8,658 shares of the business's stock in a transaction on Wednesday, December 13th. The shares were sold at an average price of $71.86, for a transaction totalling $622,163.88. Following the completion of the sale, the insider now directly owns 213,794 shares of the company's stock, valued at $15,363,236.84. Learn More on Larry L. Wood's trading history.

Who are Edwards Lifesciences' active insiders?

Edwards Lifesciences' insider roster includes Donald Bobo, Jr (VP), Daveen Chopra (VP), Kieran Gallahue (Director), Leslie Heisz (Director), Jean-Luc Lemercier (VP), Martha Marsh (Director), Michael Mussallem (CEO), Robert Sellers (VP), Catherine Szyman (VP), Scott Ullem (CFO), Nicholas Valeriani (Director), Huimin Wang (VP), Larry Wood (VP), and Bernard Zovighian (VP). Learn More on Edwards Lifesciences' active insiders.

Are insiders buying or selling shares of Edwards Lifesciences?

In the last year, insiders at the medical research company sold shares 60 times. They sold a total of 768,312 shares worth more than $62,771,727.15. The most recent insider tranaction occured on April, 8th when VP Jean-Luc M Lemercier sold 14,400 shares worth more than $1,329,408.00. Insiders at Edwards Lifesciences own 1.3% of the company. Learn More about insider trades at Edwards Lifesciences.

Information on this page was last updated on 4/8/2024.

Larry L. Wood Insider Trading History at Edwards Lifesciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/13/2023Sell8,658$71.86$622,163.88213,794View SEC Filing Icon  
11/13/2023Sell8,660$65.30$565,498.00213,794View SEC Filing Icon  
10/13/2023Sell8,660$70.00$606,200.00213,794View SEC Filing Icon  
9/14/2023Sell8,660$73.63$637,635.80213,794View SEC Filing Icon  
8/14/2023Sell6,421$79.30$509,185.30213,794View SEC Filing Icon  
7/14/2023Sell8,660$92.94$804,860.40213,794View SEC Filing Icon  
6/14/2023Sell8,660$90.15$780,699.00213,794View SEC Filing Icon  
5/24/2023Sell6,421$84.23$540,840.83213,794View SEC Filing Icon  
7/5/2022Sell7,242$95.90$694,507.80202,232View SEC Filing Icon  
5/10/2022Sell7,242$96.13$696,173.46206,069View SEC Filing Icon  
4/5/2022Sell7,242$121.03$876,499.26197,641View SEC Filing Icon  
2/8/2022Sell4,386$109.55$480,486.30View SEC Filing Icon  
12/10/2021Sell7,830$121.49$951,266.70View SEC Filing Icon  
11/10/2021Sell7,830$119.79$937,955.70View SEC Filing Icon  
10/11/2021Sell7,830$108.00$845,640.00View SEC Filing Icon  
7/12/2021Sell7,830$107.48$841,568.40379,964View SEC Filing Icon  
6/14/2021Sell7,830$99.91$782,295.30379,902View SEC Filing Icon  
5/10/2021Sell7,830$92.22$722,082.60367,679View SEC Filing Icon  
4/12/2021Sell7,830$85.84$672,127.20371,613View SEC Filing Icon  
3/1/2021Sell7,830$83.99$657,641.70371,313View SEC Filing Icon  
11/2/2020Sell10,698$73.27$783,842.46374,181View SEC Filing Icon  
10/1/2020Sell10,698$80.38$859,905.24374,181View SEC Filing Icon  
9/1/2020Sell10,698$85.09$910,292.82374,181View SEC Filing Icon  
8/3/2020Sell10,698$78.40$838,723.20374,181View SEC Filing Icon  
7/1/2020Sell10,698$68.90$737,092.20374,181View SEC Filing Icon  
6/1/2020Sell10,698$75.30$805,559.40374,097View SEC Filing Icon  
5/1/2020Sell3,566$215.00$766,690.00121,102View SEC Filing Icon  
4/1/2020Sell3,566$180.84$644,875.44121,102View SEC Filing Icon  
3/2/2020Sell3,566$207.00$738,162.00120,995View SEC Filing Icon  
2/3/2020Sell3,566$219.50$782,737.00120,995View SEC Filing Icon  
1/2/2020Sell8,568$229.98$1,970,468.64122,431View SEC Filing Icon  
11/1/2019Sell6,716$239.75$1,610,161.00124,145View SEC Filing Icon  
10/1/2019Sell6,716$218.24$1,465,699.84124,145View SEC Filing Icon  
9/3/2019Sell6,716$219.91$1,476,915.56124,145View SEC Filing Icon  
8/1/2019Sell6,716$213.31$1,432,589.96124,145View SEC Filing Icon  
7/1/2019Sell6,716$186.95$1,255,556.20124,145View SEC Filing Icon  
6/3/2019Sell6,716$169.75$1,140,041.00124,102View SEC Filing Icon  
5/1/2019Sell6,716$176.34$1,184,299.44122,495View SEC Filing Icon  
4/1/2019Sell6,716$192.34$1,291,755.44122,495View SEC Filing Icon  
3/1/2019Sell6,716$170.82$1,147,227.12122,366View SEC Filing Icon  
2/4/2019Sell6,716$169.10$1,135,675.6035,224View SEC Filing Icon  
1/7/2019Sell6,716$148.15$994,975.40122,366View SEC Filing Icon  
12/14/2018Sell6,300$162.66$1,024,758.0027,028View SEC Filing Icon  
11/15/2018Sell6,300$147.96$932,148.0025,490View SEC Filing Icon  
9/14/2018Sell6,300$146.95$925,785.00121,950View SEC Filing Icon  
7/16/2018Sell6,300$148.02$932,526.00121,950View SEC Filing Icon  
6/15/2018Sell6,300$151.86$956,718.00View SEC Filing Icon  
5/15/2018Sell6,300$137.26$864,738.00View SEC Filing Icon  
4/16/2018Sell6,300$138.97$875,511.00View SEC Filing Icon  
3/15/2018Sell6,300$141.49$891,387.00116,148View SEC Filing Icon  
2/16/2018Sell6,300$134.27$845,901.00116,148View SEC Filing Icon  
1/16/2018Sell6,300$121.00$762,300.00116,148View SEC Filing Icon  
12/15/2017Sell18,960$114.58$2,172,436.80View SEC Filing Icon  
11/15/2017Sell18,960$104.76$1,986,249.60View SEC Filing Icon  
10/16/2017Sell18,960$108.54$2,057,918.40View SEC Filing Icon  
9/15/2017Sell18,960$112.58$2,134,516.80View SEC Filing Icon  
8/30/2017Sell18,960$111.81$2,119,917.60View SEC Filing Icon  
12/1/2016Sell13,258$81.85$1,085,167.30View SEC Filing Icon  
11/1/2016Sell13,257$93.27$1,236,480.39View SEC Filing Icon  
10/3/2016Sell13,257$119.27$1,581,162.39View SEC Filing Icon  
8/1/2016Sell13,257$114.24$1,514,479.68View SEC Filing Icon  
7/1/2016Sell13,257$98.79$1,309,659.03View SEC Filing Icon  
6/3/2016Sell13,257$101.38$1,343,994.66115,083View SEC Filing Icon  
10/1/2015Sell7,680$141.52$1,086,873.6043,838View SEC Filing Icon  
9/1/2015Sell7,680$137.50$1,056,000.0043,838View SEC Filing Icon  
7/1/2015Sell7,680$143.51$1,102,156.80View SEC Filing Icon  
6/1/2015Sell7,680$130.47$1,002,009.60View SEC Filing Icon  
5/1/2015Sell7,680$127.12$976,281.60View SEC Filing Icon  
4/1/2015Sell7,680$142.06$1,091,020.80View SEC Filing Icon  
3/2/2015Sell7,680$132.62$1,018,521.60View SEC Filing Icon  
8/18/2014Sell63,752$97.85$6,238,133.20View SEC Filing Icon  
See Full Table

Larry L. Wood Buying and Selling Activity at Edwards Lifesciences

This chart shows Larry L Wood's buying and selling at Edwards Lifesciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Edwards Lifesciences Company Overview

Edwards Lifesciences logo
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $87.52
Low: $86.76
High: $87.93

50 Day Range

MA: $90.15
Low: $84.87
High: $95.56

2 Week Range

Now: $87.52
Low: $60.57
High: $96.12

Volume

1,042,677 shs

Average Volume

3,810,254 shs

Market Capitalization

$52.68 billion

P/E Ratio

38.05

Dividend Yield

N/A

Beta

1.05